Rmd Open

Rmd Open

Rmd 打开

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Rmd Open》是由BMJ PUBLISHING GROUP出版社创办的英文国际期刊(ISSN: 2056-5933,E-ISSN: 2056-5933),该期刊长期致力于风湿病学领域的创新研究,主要研究方向为RHEUMATOLOGY。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表风湿病学领域等方向的原创性研究为核心(研究类文章占比86.21%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在261篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Rmd Open审稿周期约为 14 Weeks 。该刊近年未被列入国际预警名单,年发文量约261篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 261 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
RHEUMATOLOGY 风湿病学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
RHEUMATOLOGY 风湿病学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:RHEUMATOLOGY SCIE Q1 8 / 57

86.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RHEUMATOLOGY SCIE Q1 6 / 57

90.35%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.3 SJR:1.739 SNIP:1.366
学科类别 分区 排名 百分位
大类:Medicine 小类:Rheumatology Q1 15 / 73

80%

大类:Medicine 小类:Immunology and Allergy Q2 78 / 233

66%

大类:Medicine 小类:Immunology Q2 93 / 236

60%

期刊发文

  • Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study

    Author: Leng, Xiaomei; Lin, Wei; Liu, Shixue; Kanik, Keith; Wang, Cunshan; Wan, Weiguo; Jiang, Zhenyu; Liu, Yi; Liu, Shengyun; Zhang, Zhuoli; Zhang, Zhiyi; Xu, Jian; Tan, Wenfeng; Hu, Jiankang; Li, Jingyang; Liu, Ju; Gunay, Levent M.; Dina, Oluwaseyi; Kinch, Cassandra; Zeng, Xiaofeng

    Journal: RMD OPEN. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1136/rmdopen-2022-002559

  • Phosphorylated signal transducer and activator of transcription proteins 1 in salivary glandular tissue: an important histological marker for diagnosis of primary Sjogren's syndrome

    Author: Zheng, Qing; Liu, Lingyu; Wang, Bin; He, Yan; Zhang, Mengqin; Shi, Guixiu

    Journal: RMD OPEN. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1136/rmdopen-2022-002694

  • Immunoproteasome subunit beta 5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I

    Author: Zhang, Lu; Xia, Qisheng; Li, Wenli; Liu, Qingyan; Zhang, Lining; Tian, Xiaolan; Ye, Lifang; Wang, Guochun; Peng, Qinglin

    Journal: RMD OPEN. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1136/rmdopen-2022-002818

  • Potential impact of autoimmune diseases family history in IgG4-related disease: a retrospective cohort study

    Author: Sun, Ruijie; Liu, Zheng; Lu, Hui; Peng, Yu; Li, Jieqiong; Nie, Yuxue; Li, Jingna; Peng, Linyi; Zhou, Jiaxin; Fei, Yunyun; Zeng, Xiaofeng; Zhang, Wen

    Journal: RMD OPEN. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1136/rmdopen-2022-002865

  • Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study

    Author: Jiang, Xiaofeng; Sparks, Jeffrey; Wallace, Zachary; Deng, Xinjia; Li, Hui; Lu, Na; Xie, Dongxing; Wang, Yilun; Zeng, Chao; Lei, Guanghua; Wei, Jie; Zhang, Yuqing

    Journal: RMD OPEN. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1136/rmdopen-2022-002839